secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADC Therapeutics SA (ADCT)
CIK:        0001771910
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0000950103-24-006646
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADC Therapeutics posts corporate presentation; no material new disclosures identified
--------------------------------------------------------------------------------

- Presentation dated May 14, 2024 made available for industry conferences and investor meetings.
- No specific financial or operational metrics disclosed in the 8-K or exhibit summary.
- Presentation contains forward-looking statements; limited detail on pipeline or guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771910/000095010324006646/0000950103-24-006646-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771910/000095010324006646/dp211180_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-006646

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer